185 related articles for article (PubMed ID: 33121353)
41. Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain.
Pol O; Murtra P; Caracuel L; Valverde O; Puig MM; Maldonado R
Neuropharmacology; 2006 Jan; 50(1):123-32. PubMed ID: 16360182
[TBL] [Abstract][Full Text] [Related]
42. Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation.
Kelly S; Jhaveri MD; Sagar DR; Kendall DA; Chapman V
Eur J Neurosci; 2003 Oct; 18(8):2239-43. PubMed ID: 14622184
[TBL] [Abstract][Full Text] [Related]
43. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
[TBL] [Abstract][Full Text] [Related]
44. Interaction between gamma-aminobutyric acid GABAB and cannabinoid CB1 receptors in spinal pain pathways in rat.
Naderi N; Shafaghi B; Khodayar MJ; Zarindast MR
Eur J Pharmacol; 2005 May; 514(2-3):159-64. PubMed ID: 15910802
[TBL] [Abstract][Full Text] [Related]
45. Endogenous and synthetic cannabinoids induce the downregulation of cannabinoid CB1 receptor in retina.
Papadogkonaki S; Theodorakis Κ; Thermos K
Exp Eye Res; 2019 Aug; 185():107694. PubMed ID: 31199905
[TBL] [Abstract][Full Text] [Related]
46. CB
Zheng T; Zhang R; Zhang T; Zhang MN; Xu B; Song JJ; Li N; Tang HH; Wang P; Wang R; Fang Q
Brain Res; 2018 Feb; 1680():155-164. PubMed ID: 29274880
[TBL] [Abstract][Full Text] [Related]
47. Neuroprotective effect of cannabinoid receptor 1 antagonist in the MNU-induced retinal degeneration model.
Chen Y; Luo X; Liu S; Shen Y
Exp Eye Res; 2018 Feb; 167():145-151. PubMed ID: 29126840
[TBL] [Abstract][Full Text] [Related]
48. MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future.
Simon V; Cota D
Eur J Endocrinol; 2017 Jun; 176(6):R309-R324. PubMed ID: 28246151
[TBL] [Abstract][Full Text] [Related]
49. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E
Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673
[TBL] [Abstract][Full Text] [Related]
50. Electroacupuncture Exerts Analgesic Effects by Restoring Hyperactivity via Cannabinoid Type 1 Receptors in the Anterior Cingulate Cortex in Chronic Inflammatory Pain.
Wu J; Hua L; Liu W; Yang X; Tang X; Yuan S; Zhou S; Ye Q; Cui S; Wu Z; Lai L; Tang C; Wang L; Yi W; Yao L; Xu N
Mol Neurobiol; 2024 May; 61(5):2949-2963. PubMed ID: 37957422
[TBL] [Abstract][Full Text] [Related]
51. CB
Long J; Lei X; Chen M; Yang S; Sun T; Zeng J; Yu D; Tian H; Liu X
Neurochem Res; 2018 Feb; 43(2):267-275. PubMed ID: 29127599
[TBL] [Abstract][Full Text] [Related]
52. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V
Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
[TBL] [Abstract][Full Text] [Related]
53. Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist.
Bilir KA; Anli G; Ozkan E; Gunduz O; Ulugol A
Clin Exp Dermatol; 2018 Jul; 43(5):553-558. PubMed ID: 29424035
[TBL] [Abstract][Full Text] [Related]
54. Intrathecal grafting of porcine chromaffin cells reduces formalin-evoked c-Fos expression in the rat spinal cord.
Sol JC; Li RY; Sallerin B; Jozan S; Zhou H; Lauwers-Cances V; Tortosa F; Chaynes P; Mascott C; Bastide R; Lazorthes Y
Cell Transplant; 2005; 14(6):353-65. PubMed ID: 16180654
[TBL] [Abstract][Full Text] [Related]
55. Orexinergic descending inhibitory pathway mediates linalool odor-induced analgesia in mice.
Higa Y; Kashiwadani H; Sugimura M; Kuwaki T
Sci Rep; 2021 Apr; 11(1):9224. PubMed ID: 33927235
[TBL] [Abstract][Full Text] [Related]
56. Cannabinoid 1 receptor knockout mice display cold allodynia, but enhanced recovery from spared-nerve injury-induced mechanical hypersensitivity.
Sideris A; Piskoun B; Russo L; Norcini M; Blanck T; Recio-Pinto E
Mol Pain; 2016; 12():. PubMed ID: 27206660
[TBL] [Abstract][Full Text] [Related]
57. Immunoregulation of experimental autoimmune encephalomyelitis by the selective CB1 receptor antagonist.
Lou ZY; Zhao CB; Xiao BG
J Neurosci Res; 2012 Jan; 90(1):84-95. PubMed ID: 21922514
[TBL] [Abstract][Full Text] [Related]
58. Acute rimonabant treatment promotes protein synthesis in C2C12 myotubes through a CB1-independent mechanism.
Le Bacquer O; Lanchais K; Combe K; Van Den Berghe L; Walrand S
J Cell Physiol; 2021 Apr; 236(4):2669-2683. PubMed ID: 32885412
[TBL] [Abstract][Full Text] [Related]
59. Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist.
Muller T; Demizieux L; Troy-Fioramonti S; Buch C; Leemput J; Belloir C; Pais de Barros JP; Jourdan T; Passilly-Degrace P; Fioramonti X; Le Bon AM; Vergès B; Robert JM; Degrace P
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328343
[TBL] [Abstract][Full Text] [Related]
60. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain.
Elmes SJ; Jhaveri MD; Smart D; Kendall DA; Chapman V
Eur J Neurosci; 2004 Nov; 20(9):2311-20. PubMed ID: 15525273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
